To protect our staff and visitors from COVID-19, OPA office staff will work remotely. We’ll continue to be fully operational to serve our members. Contact us at 416-441-0788 or 1-877-341-0788 or mail@opatoday.com.

OPDP Bulletins

  • OPA Bulletin - May 28, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • OPA and Neighbourhood Pharmacies oppose government's proposal to extract $140 million annually from pharmacy
    • Last chance to register for conference - registration closes Thursday!
    • Discontinuation Notice - PrDepo-Provera® (medroxyprogesterone acetate, USP) 50 mg/mL in 1 x 5 mL Vial
    • Drug Supply Health System Alert: OncoTICE
    • IMPORTANT: Notification Regarding PrNORVASC® (amlodipine besylate) 10 mg tablets in bottles of 250.
    • Re-issuing Spring Issue of Ontario Pharmacist

    • Billing 101: Ontario Drug Benefit (ODB) and Third-Party Insurance
    • How-To: Ontario’s Pharmaceutical Opinion Program
    • Asthma Management: The Essentials

    • Summer's almost here! Time to get your Canada's Wonderland passes
    • Ask the Practice Support Network

    • Are you considering Joining a Local Area Network (LAN) or Wide Area Network (WAN)?

    • DDD Notice No. 19081 posted May 23, 2019 ODB FORMULARY – EDITION NO. 43, Summary of Changes – May 2019

  • OPA Bulletin - March 26, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • OPA Process Map and Pharmacy Tool for OHIP+
    • ICYMI: Empowering Canadian Pharmacy Practice
    • Pharmacy Experience Pharmacie 2019 is open for registration!
    • Research Study: The Ontario Digital Service and Ministry of Health and Long-Term Care
    • Canadian Federation of Pharmacy Campaign Drive 1 Million for 25
    • OPA Supports Broader Discussion on Impact of Removal of Private Label Ban

    • Implementing Smoking Cessation Services in the Pharmacy
    • Asthma Management: The Essentials
    • MedsCheck Refresh: Implementing the Revitalized Program

    • Last Call for OPA Awards
    • Ask the Customer Experience and Administration Team

    • OPA Secure Health Plan Q&A
    • It's Movie Ticket Time with COSECO!

    • DDD Notice No. 19057 posted March 20, 2019 Prescription Forgery Alert
    • DDD Notice No. 19058 posted March 21, 2019 ODB FORMULARY – EDITION NO. 43, Summary of Changes – March 2019
    • DDD Notice No. 19059 posted March 25, 2019 Claim Submission/Reversal and Special Authorization (Allergen) forms

    • Extraneal peritoneal dialysis solution - Advisory
    • Important Safety Information on DARZALEX (daratumumab) and Hepatitis B Virus Reactivation - Janssen Inc.

  • OPA Bulletin - November 20, 2018

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    Pharmacy News
    • OPDP Notice No. 18145 posted November 16, 2018 Notice from the Executive Officer

    News from OPA
    • Membership and DIRC subscription campaigns open! Take advantage of early bird
    • Research and Advocacy
    • CPhA/OPA Conference - Pharmacy Experience Pharmacie (PxP) Call for Speakers
    • Ask the Customer Experience and Administration Team
    • Highlights in Professional Development​
    • OPA's PLI Insurance - Best-in-Class!

  • OPDP Notice No. 17109

    OPDP Notice No. 17109 posted September 21, 2017 ODB FORMULARY – EDITION NO. 42, Summary of Changes – September 2017 We are pleased to provide you with the Summary of Changes – September 2017 to Edition No. 42 of the Ontario Drug Benefit (ODB) …

    September 03, 2013
  • OPDP Notice No. 17108

    OPDP Notice No. 17108 posted September 21, 2017 Notice from the Executive Officer: Changes to Fentanyl Dispensing Ontario Public Drug Programs is committed to supporting the appropriate prescribing and dispensing of opioids and addressing the …

    September 03, 2013
  • OPDP BULLETINS August 23-29, 2017

    OPDP Notice No. 17100 posted August 23, 2017 ODB FORMULARY – EDITION NO. 42, Summary of Changes – August 2017 OPDP Notice No. 17101 posted August 23, 2017 Notice from the Executive Officer: Thyroid (Dessicated Thyroid) Delisting OPDP Notice …

    September 03, 2013
  • OPDP BULLETINS August 2 - 9, 2017

    OPDP Notice. 17096 posted August 3, 2017 Prescription Forgery Alert OPDP Notice No. 17097 posted August 3, 2017 Notice from the Executive Officer: Reimbursement and Claim Submissions for Mifepristone/Misoprostol (Mifegymiso) OPDP Notice No. 1 …

    September 03, 2013
  • OPDP BULLETINS July 26 - August 1, 2017

    OPDP Notice. 17092A posted July 28, 2017 Addendum to ODB Formulary – Edition 42, Summary of Changes – July 2017 OPDP Notice No.17095 posted August 1, 2017 Notice from the Executive Officer: Funding of filgrastim under the Ontario Drug Benefit …

    September 03, 2013
  • OPDP BULLETINS July 18-25, 2017

    OPDP Notice. 17091 posted July 20, 2017 E-FORMULARY OUTAGE NOTIFICATION TO ODP AGENCIES OPDP Notice. 17092 posted July 21, 2017 ODB FORMULARY – EDITION NO. 42, Summary of Changes – July 2017 OPDP Notice No. 17093 posted July 21, 2017 Notice …

    September 03, 2013
  • OPDP BULLETINS July 5-11, 2017

    OPDP Notice. 17082 posted July 5, 2017 CPSO Notices June 2017 - Release 1 of 2 OPDP Notice. 17083 posted July 5, 2017 CPSO Notices June 2017 - Release 2 of 2 OPDP Notice. 17084 posted July 7, 2017 E-FORMULARY OUTAGE NOTIFICATION TO ODP …

    September 03, 2013
  • OPDP BULLETINS June 28 - July 4, 2017

    OPDP Notice. 17080 posted June 30, 2017 Notice from the Executive Office OPDP Notice. 17080 posted June 30, 2017 Notice from the Executive OfficeNotice from the Executive OfficerJune 30, 2017 This notice is to advise health care …

    September 03, 2013
  • OPDP BULLETINS June 14-23, 2017

    OPDP Notice. 17069 posted June 14, 2017 CPSO Notices - March 2017, Release 1 of 2 OPDP Notice. 17070 posted June 14, 2017 CPSO Notices - March 2017, Release 2 of 2 OPDP Notice. 17071 posted June 15, 2017 CPSO Notices - April 2017, Release 1 …

    September 03, 2013
  • OPDP BULLETINS June 7-13, 2017

    OPDP Notice. 17067 posted June 09, 2017 CPSO Notice OPDP Notice. 17068 posted June 09, 2017 CPSO Notice OPDP Notice. 17067 posted June 09, 2017 CPSO NoticePlease be advised of the following public notices issued by the College of …

    September 03, 2013
  • OPDP BULLETINS MAY 31 - JUNE 6, 2017

    OPDP Notice No. 17066 posted June 2, 2017 Information Bulletin: Update on the Publicly Funded Influenza Vaccines for Ontario Pharmacies OPDP Notice No. 17066 posted June 2, 2017 Information Bulletin: Update on the Publicly Funded …

    September 03, 2013
  • OPDP BULLETINS MAY 24-30, 2017

    OPDP Notice No. 17061 posted May 24, 2017 Prescription Forgery Alert OPDP Notice No. 17062 posted May 24, 2017 Prescription Forgery Alert  OPDP Notice No. 17063 posted May 24, 2017 Prescription Forgery Alert  OPDP Notice No. 17064 posted …

    September 03, 2013
  • OPDP BULLETINS MAY 17-23, 2017

    OPDP Notice No. 17060 posted May 23, 2017 ODB FORMULARY – EDITION NO. 42, Summary of Changes – May 2017 SUMMARY OF PRODUCT CHANGES ODB FORMULARY – EDITION NO. 42, Summary of Changes – May 2017 SUMMARY OF PRODUCT CHANGES   We are pleased to …

    September 03, 2013
  • OPDP BULLETINS MAY 3-9, 2017

    OPDP Notice. 17056 posted May 05, 2017 CPSO Notice OPDP Notice. 17057 posted May 05, 2017 CPSO Notice OPDP Notice. 17056 posted May 05, 2017 CPSO Notice Please be advised of the following public notices issued by the College of Physicians …

    September 03, 2013
  • OPDP BULLETINS APRIL 26 - MAY 2, 2017

    Addendum to OPDP Notice No. 17051 (ODB Formulary – Edition 42, Summary of Changes – April 2017) OPDP Notice No. 17054 posted April 27, 2017 Notice from the Executive Officer OPDP Notice. 17055 posted April 28, 2017 Prescription …

    September 03, 2013
  • OPDP BULLETINS APRIL 19-25, 2017

    OPDP Notice No. 17051 posted April 20, 2017 ODB FORMULARY EDITION NO. 42 APRIL 2017 UPDATE SUMMARY OF PRODUCT CHANGES OPDP Notice No. 17053 posted April 21, 2017 Information Bulletin: Update on the Ontario Naloxone Program for Pharmacies …

    September 03, 2013
  • OPDP BULLETINS APRIL 5-11, 2017

    OPDP Notice. 17049 posted April 10, 2017 Prescription Forgery Alert Prescription Forgery Alert   A physician has notified the ministry that a prescription pad containing approximately 25 sheets has been taken from his office.  The physician’s …

    September 03, 2013
  • OPDP BULLETINS MARCH 29-APRIL 4, 2017

    OPDP Notice.17046 posted March 31, 2017, e-Formulary Outage Notice OPDP Notice. 17048 posted April 03, 2017 Prescription Forgery Alert OPDP Notice.17046 posted March 31, 2017, e-Formulary Outage Notice e-FORMULARY OUTAGE NOTIFICATION TO …

    September 03, 2013
  • OPDP BULLETINS MARCH 22-28, 2017

    OPDP Notice No. 17043 posted March 22, 2017 ODB FORMULARY – EDITION NO. 42, Summary of Changes – March 2017 OPDP Notice No.17044 ODB Program Payment Dates 2017-18 OPDP Notice No. 17045 - Monitored Drugs List (MDL) Update OPDP Notice No. 17043 …

    September 03, 2013
  • OPDP BULLETINS MARCH 15-21, 2017

    OPDP Notice No. 17037 posted March 15, 2017 Prescription Forgery Alert OPDP Notice No. 17038 posted March 16, 2017 Prescription Forgery Alert OPDP Notice No. 17039 posted March 16, 2017 Notice from the Executive Officer: Pan-Canadian Select …

    September 03, 2013
  • OPDP BULLETINS MARCH 1-7, 2017

    OPDP Notice No. 17033 posted March 3, 2017 Prescription Forgery Alert OPDP Notice No. 17034 posted March 3, 2017 Prescription Forgery Alert OPDP Notice No. 17033 posted March 3, 2017 Prescription Forgery Alert Prescription Forgery Alert …

    September 03, 2013
  • OPDP BULLETINS FEBRUARY 22-28, 2017

    OPDP Notice No. 17029 posted February 21, 2017 ODB FORMULARY – EDITION NO. 42, Summary of Changes – February 2017 OPDP Notice No. 17030 posted February 21, 2017 Notice from the Executive Officer: Funding of Hepatitis C drug products under the …

    September 03, 2013
  • OPDP BULLETINS FEBRUARY 1-7, 2017

    OPDP Notice No. 17019 posted February 03, 2017 Prescription Forgery Alert OPDP Notice No. 17020 posted February 03, 2017 Prescription Forgery Alert OPDP Notice No. 17021 posted February 03, 2017 Prescription Forgery Alert OPDP Notice No. 17022 …

    September 03, 2013
  • OPDP BULLETINS JANUARY 11-17, 2017

    OPDP Notice No. 17007 posted January 11, 2017 Reminder regarding Delisting of High-Strength Long-Acting Opioids under the Ontario Drug Benefit (ODB) Program OPDP Notice No. 17008 posted January 13, 2017 HEALTH NETWORK SYSTEM (HNS) AND NARCOTICS …

    September 03, 2013
  • OPDP BULLETINS JANUARY 4-10, 2017

    OPDP Notice No. 17003 posted January 04, 2017 Reminder regarding Delisting of High-Strength Long-Acting Opioids under the Ontario Drug Benefit (ODB) Program Ontario Public Drug Programs, Ministry of Health and Long-Term Care Reminder regarding …

    September 03, 2013
  • OPDP BULLETINS DECEMBER 29-JANUARY 3, 2016

    OPDP Notice No. 17001 posted January 03, 2017 CPSO Notice OPDP Notice No. 17002 posted January 03, 2017 CPSO Notice OPDP Notice No. 17001 posted January 03, 2017 CPSO Notice Please be advised of the following public notices issued by the …

    September 03, 2013
  • OPDP BULLETINS DECEMBER 21-28, 2016

    OPDP Notice No. 16164 posted December 21, 2016 Notice from the Executive Officer: Funding of Grastofil (filgrastim) under the Ontario Drug Benefit program OPDP Notice No. 16164A posted December 21, 2016 RE: Notice from the Executive Officer: …

    September 03, 2013
  • OPDP BULLETINS DECEMBER 14-20, 2016

    OPDP Notice No. 16155 posted December 14, 2016 Reminder regarding Delisting of High-Strength Long-Acting Opioids under the Ontario Drug Benefit (ODB) Program OPDP Notice No. 16156 posted December 15, 2016 Prescription Forgery Alert OPDP Notice …

    September 03, 2013
  • OPDP BULLETINS DECEMBER 7-13, 2016

    OPDP Notice No. 16153 posted December 9, 2016 Updated Notice from the Executive Officer: New Health Network System Response Message for Blood Glucose Test Strip Claims OPDP Notice No. 16154 posted December 9, 2016 HEALTH NETWORK SYSTEM (HNS) …

    September 03, 2013
  • OPDP BULLETINS NOVEMBER 23-29, 2016

    OPDP Notice No. 16139 posted November 23, 2016 Re: ODB Formulary - Edition No. 42, Summary of Changes – November 2016 OPDP Notice No. 16140 posted November 24, 2016 Re: Prescription Forgery Alert OPDP Notice No. 16141 posted November 25, 2016 …

    September 03, 2013
  • OPDP BULLETINS NOVEMBER 2-8, 2016

    OPDP Notice No. 16135 posted November 4, 2016 Re: Notice from the EO - Monitored Drugs List (MDL) Update OPDP Notice No. 16136 posted November 7, 2016 Re: Facilitated Access to Palliative Care drugs for ODB eligible persons OPDP Notice No. …

    September 03, 2013
  • OPDP BULLETINS OCTOBER 26-NOVEMBER 1, 2016

    OPDP Notice No. 16133 posted October 31, 2016 Re: Prescription Forgery Alert OPDP Notice No. 16134 posted October 31, 2016 Re: Prescription Forgery Alert OPDP Notice No. 16133 posted October 31, 2016 Re: Prescription Forgery Alert     …

    September 03, 2013
  • OPDP BULLETINS OCTOBER 19-25, 2016

    OPDP Notice No. 16129 posted October 19, 2016 Re: ODB Formulary - Edition No. 42, Summary of Changes – October 2016 OPDP Notice No. 16130 posted October 20, 2016 Re: Notice from the EO - Pharmacist Administration of Publicly Funded Influenza …

    September 03, 2013
  • OPDP BULLETINS OCTOBER 12-18, 2016

    OPDP Notice No. 16125 posted October 17, 2016 Re: Prescription Forgery Alert OPDP Notice No. 16126 posted October 17, 2016 Re: CPSO Notice OPDP Notice No. 16127 posted October 17, 2016 Re: CPSO Notice OPDP Notice No. 16128 posted October 18, 2 …

    September 03, 2013
  • OPDP BULLETINS OCTOBER 5-11, 2016

    OPDP Notice No. 16122 posted October 7, 2016 Re: Notice from the EO - Application of Generic Substitution to the Exceptional Access Program (EAP) OPDP Notice No. 16123 posted October 7, 2016 Re: ODB Formulary - Edition No. 42, Summary of …

    September 03, 2013
  • OPDP BULLETINS SEPTEMBER 21-27, 2016

    OPDP Notice No. 16113 posted September 21, 2016 Re: ODB Formulary - Edition No. 42, Summary of Changes – September 2016 OPDP Notice No. 16114 posted September 22, 2016 Re: Prescription Forgery Alert OPDP Notice No. 16115 posted September 22, 20 …

    September 03, 2013
  • OPDP BULLETINS SEPTEMBER 14-20, 2016

    OPDP Notice No. 16111 posted September 16, 2016 Notice from the EO: Regulation to support the Safeguarding our Communities Act, 2015 (Patch for Patch Return Program) OPDP Notice No. 16111A posted September 16, 2016 Re: FAQs – Implementation of …

    September 03, 2013
  • OPDP BULLETINS SEPTEMBER 7-13, 2016

      OPDP Notice No. 16109 posted September 8, 2016 Re: CPSO Notice OPDP Notice No. 16110 posted September 12, 2016 Re: CPSO Notice OPDP Notice No. 16109 posted September 8, 2016 Re: CPSO Notice     Please be advised of the following …

    September 03, 2013
  • OPDP BULLETINS AUGUST 31-SEPTEMBER 6, 2016

    OPDP Notice No. 16105 posted August 31, 2016 Re: Notice to Pharmacies - Canada Post Labour Negotiations and September 2016 Drug Benefit Eligibility Cards     NOTICE TO PHARMACIES   Re: Canada Post Labour Negotiations and September 2016 Drug …

    September 03, 2013
  • OPDP BULLETINS AUGUST 24-30, 2016

    OPDP Notice No. 16103 posted August 26, 2016 Re: Prescription Forgery OPDP Notice No. 16102A posted August 19, 2016 Re: Addendum to ODB Formulary - Edition No. Summary of Changes - August 2016 OPDP Notice No. 16104 posted August 30, 2016 Re: …

    September 03, 2013
  • OPDP BULLETINS AUGUST 17-23, 2016

    OPDP Notice No. 16098 posted August 17, 2016 Re: Notice from the EO: Ontario Naloxone Program for Pharmacies (ONPP) OPDP Notice No. 16099 posted August 17, 2016 Re: Notice from the EO: Reminder – the Ontario Naloxone Program for Pharmacies …

    September 03, 2013
  • OPDP BULLETINS JULY 20-26, 2016

    OPDP Notice No. 16087 posted July 20, 2016 Re: ODB Formulary - Edition No. 42, Summary of Changes – July 2016 OPDP Notice No. 16088 posted July 20, 2016 Re: Notice from the EO - Changes to the Ontario Drug Benefit (ODB) Program Funding of …

    September 03, 2013
  • OPDP BULLETINS JULY 13-19, 2016

    OPDP Notice No. 16085 posted July 15, 2016 Re: Notice from the EO - Monitored Drugs List (MDL) Update OPDP Notice No. 16086 posted July 15, 2016 Re: Prescription Forgery Alert OPDP Notice No. 16085 posted July 15, 2016 Re: Notice from the …

    September 03, 2013
  • OPDP BULLETINS JULY 6-12, 2016

    OPDP Notice No. 16080 posted July 7, 2016 Re: CPSO Notice OPDP Notice No. 16081 posted July 7, 2016 Re: CPSO Notice OPDP Notice No. 16078A posted July 11, 2016 Re: Notice to Pharmacies - Canada Post Labour Negotiations and July 2016 Drug …

    September 03, 2013
  • OPDP BULLETINS JUNE 29-JULY 5, 2016

    OPDP Notice No. 16076 posted June 29, 2016 Re: Notice from the Executive Office - Ontario Naloxone Program for Pharmacies (ONPP) - Phase 2 OPDP Notice No. 16077 posted June 29, 2016 Re: Ontario Naloxone Program for Pharmacies (ONPP) - FAQ's for …

    September 03, 2013
  • OPDP BULLETINS JUNE 15-21, 2016

    OPDP Notice No. 16072 posted June 16, 2016 Re: Prescription Forgery Alert OPDP Notice No. 16073 posted June 20, 2016 Re: Health Network System and Narcotics Monitoring System Outage Notification to Ontario Drug Programs Agencies OPDP Notice No. …

    September 03, 2013
  • OPDP BULLETINS JUNE 8-14, 2016

    OPDP Notice No. 16068 posted June 9, 2016 Re: E-Formulary Outage Notification to ODP Agencies OPDP Notice No. 16069 posted June 10, 2016 Re: Notice from the Executive Officer - HNS Changes to Support the Maximizing Quantity Dispensed for …

    September 03, 2013
  • OPDP BULLETINS JUNE 1-7, 2016

    OPDP Notice No. 16053 Posted June 1, 2016 Re: Proposal to amend Ontario Regulation 201/96 under the Ontario Drug Benefit Act and Regulation 935 under the Drug Interchangeability and Dispensing Fee Act OPDP Notice No. 16054 Posted June 1, 2016 …

    September 03, 2013
  • OPDP BULLETINS MAY 18-24, 2016

    OPDP Notice No. 16050 posted May 18, 2016 Re: Prescription Forgery Alert OPDP Notice No. 16051 posted May 20, 2016 Re: ODB Formulary - Edition No. 42, Summary of Changes – May 2016 OPDP Notice No. 16052 posted May 20, 2016 Re: Notice from the …

    September 03, 2013
  • OPDP BULLETINS MAY 4-10, 2016

    OPDP Notice No. 16042 posted May 4, 2016 Re: Prescription Forgery Alert OPDP Notice No. 16043 posted May 5, 2016 Re: CPSO Notice OPDP Notice No. 16044 posted May 5, 2016 Re: CPSO Notice OPDP Notice No. 16046 posted May 6, 2016 Re: …

    September 03, 2013
  • OPDP BULLETINS APRIL 20-26, 2016

    OPDP Notice No. 16039 posted April 21, 2016 Re: ODB Formulary - Edition No. 42, Summary of Changes - April 2016 OPDP Notice No. 16040 posted April 26, 2016 Re: Prescription Forgery OPDP Notice No. 16039 posted April 21, 2016 Re: ODB …

    September 03, 2013
  • OPDP BULLETINS APRIL 13-19, 2016

    OPDP Notice No. 16038 posted April 15, 2016 Re: Notice from the EO - Regulation Amendments to Expand Access to the SCP Program under the ODB Program     Ontario Public Drug Programs Division, Ministry of Health and Long-Term Care   Regulation …

    September 03, 2013
  • OPDP BULLETINS APRIL 6-12, 2016

    OPDP Notice No. 16035 posted April 5, 2016 Re: Prescription Forgery     Prescription Forgery   The ministry has been notified that prescription forgeries have been identified at pharmacies in the Islington/Etobicoke area.  The physician …

    September 03, 2013
  • OPDP BULLETINS MARCH 30-APRIL 5 2016

    OPDP Notice No. 16033 posted April 1, 2016 Re: Notice from the EO - Monitored Drugs List (MDL) Update OPDP Notice No. 16034 posted April 1, 2016 Re: CPSO Notice OPDP Notice No. 16033 posted April 1, 2016 Re: Notice from the EO - Monitored …

    September 03, 2013
  • OPDP BULLETINS MARCH 23-29 2016

    OPDP Notice No. 16032 posted March 24, 2016 Re: Prescription Forgery     Prescription Forgery   The ministry has been notified that prescription forgeries have been identified at a pharmacy in Ottawa.  The physician reporting the forgeries is: …

    September 03, 2013
  • OPDP BULLETINS MARCH 16-22, 2016

    OPDP Notice No. 16029 posted March 18, 2016 Re: Prescription Forgery OPDP Notice No. 16030 posted March 22, 2016 Re: ODB Formulary - Edition No. 42, Summary of Changes – March 2016 OPDP Notice No. 16029 posted March 18, 2016 Re: Prescription …

    September 03, 2013
  • OPDP BULLETINS MARCH 9-15, 2016

    OPDP Notice No. 16026 posted March 11, 2016 Re: Notice from the EO - Funding of Inflectra (infliximab) Under the ODB Program OPDP Notice No. 16026A posted March 11, 2016 Re: Inflectra (infliximab) Frequently Asked Questions OPDP Notice No. 1602 …

    September 03, 2013
  • OPDP BULLETINS MARCH 2-8, 2016

    OPDP Notice No. 16021 posted March 3, 2016 Re: CPSO Notice OPDP Notice No. 16022 posted March 3, 2016 Re: CPSO Notice OPDP Notice No. 16023 posted March 8, 2016 Re: Prescription Forgery OPDP Notice No. 16021 posted March 3, 2016 Re: CPSO …

    September 03, 2013
  • OPDP BULLETINS FEBRUARY 24-MARCH 1, 2016

    OPDP Notice No. 16017 posted February 25, 2016 Re: Notice from the EO - Monitored Drugs List (MDL) Update OPDP Notice No. 16018 posted February 29, 2016 Re: Notice from the EO - Proposal to amend Ontario Regulation 201/96 under the Ontario Drug …

    September 03, 2013
  • OPDP BULLETINS FEBRUARY 17-23 2016

    OPDP Notice No. 16016 posted February 22, 2016 Re: HNS & NMS Outage Notification to ODP Agencies   HEALTH NETWORK SYSTEM (HNS) AND NARCOTICS MONITORING SYSTEM (NMS) OUTAGE NOTIFICATION TO ODP AGENCIES Schedule of Network Downtime Please be …

    September 03, 2013
  • OPDP BULLETINS FEBRUARY 10-16, 2016

    OPDP Notice No. 16013 posted February 12, 2016 Re: Notice from the EO - Monitored Drugs List (MDL) Update OPDP Notice No. 16015 posted February 16, 2016 Re: ODB Formulary - Edition No. 42, Summary of Changes – February 2016 OPDP Notice …

    September 03, 2013
  • OPDP BULLETINS FEBRUARY 3-9, 2016

    OPDP Notice No. 16010 posted February 3, 2016 Re: E-Formulary Outage Notification to ODP Agencies E-Formulary Outage Notification to ODP Agencies  Please be advised of the following outage to accommodate scheduled maintenance. Between 05:00 p.m. …

    September 03, 2013
  • OPDP BULLETINS JANUARY 26 - FEBRUARY 2, 2016

    OPDP Notice No. 16007 posted January 27, 2016 Re: Prescription Forgery OPDP Notice No. 16009 posted February 1, 2016 Re: CPSO Notice OPDP Notice No. 16007 posted January 27, 2016 Re: Prescription Forgery Prescription Forgery The ministry …

    September 03, 2013
  • OPDP BULLETINS JANUARY 20-26, 2016

    OPDP Notice No. 16006 posted January 26, 2016 Re: Prescription Forgery Prescription Forgery The ministry has been notified that multiple prescription forgeries have been identified at pharmacies in the Toronto area.  The physician reporting the …

    September 03, 2013
  • OPDP BULLETINS Jan 13 - Jan 19, 2016

    OPDP Notice No. 16001 posted January 15, 2016 Re: CPSO Notice OPDP Notice No. 16002 posted January 15, 2016 Re: CPSO Notice OPDP Notice No. 16005 posted January 19, 2016 Re: ODB Formulary - Edition No. 42, Summary of Changes – January 2016 …

    September 03, 2013
  • OPDP BULLETINS DEC 23 - DEC 29, 2015

    OPDP Notice No. 15107 posted December 24, 2015 Re: Prescription Forgery Prescription Forgery OPDP Notice No. 15108 posted December 24, 2015 Re: Prescription Forgery - Addition to OPDP Notice No. 15088 posted November 6, 2015 OPDP Notice No. 1 …

    September 03, 2013
  • OPDP Bulletins Dec 16 - Dec 22, 2015

    OPDP Notice No. 15104 posted December 18, 2015 Re: Notice from the EO - Monitored Drugs List (MDL) Update OPDP Notice No. 15104 posted December 18, 2015 Re: Notice from the EO - Monitored Drugs List (MDL) Update Notice from the Executive …

    September 03, 2013
  • OPDP Bulletins Dec 9 - Dec 15, 2015

    OPDP Notice No. 15101 posted December 9, 2015 Re: CPSO Notice OPDP Notice No. 15102 posted December 9, 2015 Re: CPSO Notice OPDP Notice No. 15103 posted December 15, 2015 Re: ODB Formulary - Edition No. 42, Summary of Changes – December 2015 …

    September 03, 2013
  • OPDP Bulletins Nov 25 - Dec 1, 2015

    OPDP Notice No. 15099 posted November 25, 2015 Re: ODB FORMULARY – EDITION NO. 42, DECEMBER 1, 2015 UPDATE ACCORDING TO THE NEW BLOOD GLUCOSE TEST STRIP (BGTS) REIMBURSEMENT POLICY OPDP Notice No. 15100 posted November 27, 2015 Re: Prescription …

    September 03, 2013
Back to top